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1 Introduction
Besides pulmonary edema, myocardial damage
is mostly feared during tocolytic treatment with
betasympathomimetic agents. In 1959, RONA de-
scribed infarct-like lesions under isoproterenol in
the rat [15]. Also in man, myolyses, nuclear fad-
ings and other hypoxic lesions have been re-
ported [1, 2, 3, 17]. Polytope ventricular extra-
systoles, ST-depression and T-flattenings have
been found in ECG [6, 18]. These pathologic
events, if diagnosed, often lead to discontinua-
tion of tocolysis resulting in the birth of a pre-
mature child [8, 9].
Numerous laboratory investigations have been
performed on cardiac side effects of betamimet-
ics. In our laboratory, no change in heart-specific
CK-MB under ritodrine-verapamil [10], but im-
pressive increases of myoglobin under hexopren-
aline without cardioprotective agents [11] were
observed. In contrast, no change of serum myo-
globin could be demonstrated, if the betat-block-
ing substance metoprolol or the calcium-entry
blocker verapamil were added to the betamimet-
ics [12, 13].
In ongoing search for an even more specific
diagnosis of ischemic myocardial lesions, the de-
termination of heart specific light-chain L-
myosin was performed by means of a mono-
clonal antibody [7]. Using this antibody, we had
the opportunity to investigate L-myosin under
tocolysis with hexoprenaline-metoprolol in com-
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2 Material and methods
L-myosin was determined using a recently de-
veloped monoclonal antibody in 51 women with
uncomplicated pregnancies in the 28th—41st week
of gestation. In 15 healthy women, who were
treated with intravenous infusion containing
hexoprenaline (0.3 μ/min) and metoprolol (0.01
mg/min) because of threatening premature birth,
plasma L-myosin was investigated before as well
as 2, 6, 12 and 24 hours after beginning of
tocolysis.
Blood was drawn into EDTA tubes. After cen-
trifugation, plasma was freezed at — 20 °C. L-
myosin concentration was measured by means
of a recently developed enzyme-immuno-assay
of BOEHRINGER/MANNHEIM, FRG, on ES22 (En-
zyme-immuno-assay system 22).
1989 by Walter de Gruyter & Co. Berlin · New York
462 Lechner et al., Myosin during tocolysis
3 Results
The results derived from normal pregnancies are
demonstrated in table I. Figure 1 shows the L-
myosin values before and 2, 6, 12 and 24 hours
after the beginning of tocolysis with hexopren-
aline-metoprolol. There is an increase in the me-
dian and 90th percentile values, but no statisti-
cally significant difference between these values
Table I. Plasma L-myosin values in pregnant












Figure 1. L-myosin values in 15 patients before and
under tocolysis with hexoprenaline-metoprolol compa-
red to 51 controls (dotted lines: median, 20th and 80th
percentile of controls).
and the normal ones could be shown (range
variance analysis after KRUSKAL-WALLIS, [16]).
For ethical reasons, we did not treat patients
with hexoprenaline alone, because we had found
impressive increases of rnyoglobin values during
monotherapy with beta-sympathomimetics [11].
4 Discussion
Together with actin, myosin is working as a
contractile protein in heart, sceletal and smooth
musculature. The molecule is about 1600 A in
length, its weight is about 500000 daltons. It
consists of two parts: a) the head, which is com-
posed of two "heavy chains" with two "light
chains" each and is able to hydrolize ATP and
to enter into connection with the corresponding
actin-molecule and b) the tail which consists of
two helical protein chains transmitting the con-
tractions caused by the head onto the myoflla-
ments. The contractile state of a muscle is defined
by the phosphorylation or dephosphorylation of
the myosin light chains by a corresponding ki-
nase or phosphatase. The myosin light chain
kinase is activated by Ca++-calmodulin [4, 5].
There are several organospeciflc forms of
myosin. Their heavy chains (MW 200000 dal-
tons) are common, and they differ in their light-
chains. L-myosin specific for myocardium has a
molecular weight of 12000 daltons. It exists in
two forms: free cytosolic L-myosin is raising in
the serum 3 — 6 h after a myocardial necrosis has
taken place, while particular-bound L-myosin
levels are high from 22 hours up to two weeks
[7]. L-myosin being liberated independently from
the perfusion in contrast to CK-MB and myo-
globin represents most precisely the number of
destroyed cardiomyocytes and therefore it is the
best marker for the extension of the destroyed
myocardial area [14]. Another significant point
is the above mentioned possibility to verify it up
to two weeks.
These investigations show that a hypoxic my-
ocardial damage can be widely excluded for a
tocolysis with hexoprenaline-metoprolol.
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Abstract
Cardiac toxicity of tocolysis containing hexoprenaline
(0.3 §/ ) and the betai-blocking agent metoprolol
(0.01 mg/min) was investigated using a recently devel-
oped monoclonal antibody arised against light-chain
myosin in 15 patients and compared with the results
in 51 control subjects. There was an increase in the
median and 80th percentile values 2, 6,12 and 24 hours
after the beginning of tocolysis but no statistically
significant difference between these values and the
normal ones could be shown.
Keywords: Light-chain myosin, myocardial damage, tocolysis.
Zusammenfassung
Bestimmung der Myosin-L-Ketten in der Schwanger-
schaft und bei Tokolyse
Ein Myokardschaden ist eine der schwerwiegendsten
Komplikationen bei der Tokolyse mit betamimetischen
Substanzen. Die Laboruntersuchungen umfassen die
Bestimmung der Creatinin-Kinase-MB, der Myoglo-
bine und, seit neuestem, der L-Ketten im Myosin durch
einen monoklonalen Antikörper. Wir bestimmten das
L-Myosin im Plasma von 15 sonst gesunden Frauen,
die intravenös Hexoprenalin (0,3 g/min) und Meto-
prolol (0,01 mg/min) erhielten. Die Blutentnahmen
erfolgten vor sowie 2, 6, 12 und 24 Stunden nach
Beginn der Tokolyse. 51 Frauen ohne Komplikationen
in der Schwangerschaft bildeten die Kontrollgruppe.
Wir beobachteten einen Anstieg des Medianwertes und
der Werte der 80er Perzentile, jedoch ließen sich keine
statistisch signifikanten Unterschiede im Vergleich mit
der Kontrollgruppe sichern (Abb. 1).
Zusammenfassend konnten wir bei unseren Patientin-
nen, die eine Tokolyse mit Hexoprenalin und Meto-
prolol erhielten, Myokardnekrosen ausschließen.
Schlüsselwörter: Myosin-L-Ketten, Myokardschaden, Tokolyse.
Resume
Determination de la myosine a chaine legere au cours
de la grossesse et pendant la tocolyse
Les lesions myocardiques representent une des compli-
cations les plus graves au cours de la tocolyse par beta-
mimetiques. Les examens de laboratoire comprennent
les mesures de la creatinine kinase, des myoglobines
et, depuis peu, de la (L)myosine a chaine legere ä l'aide
d'un anticorps monoclonal. Nous avons dose la L-
Myosine dans le plasma de 15 femmes, bien portantes
par ailleurs, traitees par perfusion intra-veineuse
d'hexoprenaline (0,3 g/min) et de metoprolol (0,01
Mots-cles: Lesions myocardiques, myosine a chaine legere, tocolyse.
mg/min). Les prelevements sanguins ont ete effectues
2, 6, 12 et 24 heures apres le debut de la tocolyse. 51
femmes sans complications gravidiques ont servi de
temoins. II existe une augmentation de la moyenne et
des valeurs du SOeme percentile, mais pas de difference
statistiquement significative en comparaison avec les
temoins (figure 1).
Au total, chez nos patientes sous tocolyse par hexo-
prenaline-metoprolol, on peut eliminer une necrose
myocardique.
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